Therapeutic drug monitoring of infliximab biosimilar and anti-infliximab antibodies in inflammatory diseases

被引：0
|
作者：
Elberdin, Laida [1 ]
Outeda, Maria [1 ]
Mateos, Maria [1 ]
Martinez, Cristina [1 ]
Salvador, Pilar [1 ]
Angeles Porta, Maria [1 ]
Isabel Martin, Maria [1 ]
机构：
[1] A Coruna Univ Hosp Complex, Integrated Adm Management, Dept Pharm, La Coruna, Spain
来源：
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY | 2017年 / 39卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
TDMP011
引用
收藏
页码：338 / 339
页数：2
相关论文
共 50 条
  • [1] Therapeutic drug monitoring countering the effect of anti-infliximab antibodies
    Hooijberg, Femke
    Wolbink, Gertjan
    [J]. LANCET RHEUMATOLOGY, 2024, 6 (04): : e193 - e194
  • [2] Serum trough infliximab and anti-infliximab antibodies in a cohort of gastroenterology and rheumatology patients' infliximab therapeutic drug monitoring
    Barlow, Nicola L.
    Mohammed, Pervaz
    Berg, Jonathan D.
    [J]. ANNALS OF CLINICAL BIOCHEMISTRY, 2016, 53 (04) : 477 - 484
  • [3] Evaluation of Infliximab and Anti-infliximab LISA-TRACKER Immunoassays for the Therapeutic Drug Monitoring of SB2 Infliximab Biosimilar
    Jentzer, Alexandre
    Berger, Anne-Emmanuelle
    Labetoulle, Remi
    Haccourt, Alice
    Roblin, Xavier
    Paul, Stephane
    [J]. THERAPEUTIC DRUG MONITORING, 2018, 40 (06) : 749 - 753
  • [4] Detectable Anti-Infliximab Antibodies in Children Treated with Infliximab for Rheumatic Diseases
    Aeschlimann, Florence A.
    Hofer, Kevin
    Schneider, Elvira Cannizzaro
    Schroeder, Silke
    Lauener, Roger
    van der Kleij, Desiree
    Rispens, Theo
    Saurenmann, R. K.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S7 - S7
  • [5] Anti-infliximab antibodies in pediatric patients with rheumatic diseases treated with infliximab
    Kosmac, Miha
    Avcin, Tadej
    Toplak, Natasa
    Simonini, Gabriele
    Cimaz, Rolando
    Serbec, Vladka Curin
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (02) : 385 - 386
  • [6] Monitoring of infliximab trough levels and anti-infliximab antibodies in inflammatory bowel diseases: A comparison of three commercially available ELISA kits
    Bertin, Daniel
    Serrero, Melanie
    Grimaud, Jean Charles
    Desjeux, Ariadne
    Desplat-Jego, Sophie
    [J]. CYTOKINE, 2020, 126
  • [7] Anti-infliximab antibodies and low infliximab levels correlate with drug discontinuation in pediatric inflammatory bowel disease
    Zitomersky, Naamah
    Chi, Lisa
    Liu, Enju
    Bray, Kurtis R.
    Papamichael, Konstantinos
    Cheifetz, Adam S.
    Snapper, Scott B.
    Bousvaros, Athos
    Silvester, Jocelyn A.
    [J]. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2024, 78 (02): : 261 - 271
  • [8] Commentary: detection of infliximab levels and anti-infliximab antibodies
    Seow, C. H.
    Panaccione, R.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 37 (01) : 153 - 154
  • [9] ISOTYPE CHARACTERIZATION OF ANTI-INFLIXIMAB ANTIBODIES IN PEDIATRIC PATIENTS WITH RHEUMATIC DISEASES TREATED WITH INFLIXIMAB
    Kosmac, M.
    Toplak, N.
    Simonini, G.
    Cimaz, R.
    Serbec, V. Curin
    Avcin, T.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 255 - 255
  • [10] Development of anti-infliximab antibodies increases infliximab clearance in chronic inflammatory bowel disease
    Ternant, D.
    Aubourg, A.
    Magdelaine-Beuzelin, C.
    Degenne, D.
    Watier, H.
    Picon, L.
    Paintaud, G.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2008, 22 : 23 - 23
12345